Journal of Histochemistry and Cytochemistry, Vol. 50, 549-556, April 2002, Copyright © 2002, The Histochemical Society, Inc.


ARTICLE

Localization of NTPDase1/CD39 in Normal and Transformed Human Pancreas

Agnes Kittela, Marta Garridob, and Gábor Vargaa
a Department of Pathophysiology, Laboratory of Gastrointestinal Research, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary,
b Institut Municipal d'Investigació Medica, Universitat Pompeu Fabra, Barcelona, Spain

Correspondence to: Agnes Kittel, Inst. of Experimental Medicine, Hungarian Academy of Sciences, PO Box 67, 1450 Budapest, Hungary. E-mail: kittel@koki.hu


  Summary
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Elevated levels of extracellular ATP have been observed in many tumors. We have localized NTPDase1/CD39, one of the principal extracellular nucleotide-hydrolyzing enzymes, in normal and cancerous human pancreas. NTPDase/E-ATPDase activity was demonstrated with an enzyme histochemical technique on cryosections of human pancreas. Acinar and duct epithelial cells were devoid of E-ATPDase activity in both normal and transformed tissue. Endothelial cells and smooth muscle around blood vessels and larger ducts showed strong activity. Nerves, connective tissue, and the ß-cells of the islets were also stained. In cancerous tissue this activity was diminished in the smooth muscle around the ducts and was absent from newly formed connective tissue. Immunostaining for CD39 supported these results but revealed the presence of inactive CD39 in the duct epithelial cells. We hypothesize that the significantly diminished activity of NTPDase1 in the tissues surrounding the ducts may be associated with the processes that lead to tumor formation in human pancreas. (J Histochem Cytochem 50:549–555, 2002)

Key Words: NTPDase1/CD39, extracellular nucleotides, ATP, purinoceptors, pancreas, tumor, islets


  Introduction
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

The metabolism of extracellular nucleotides plays an important role in nucleotide signaling mediated by ATP- and ADP-selective P2 receptors. ATP is degraded via ADP and AMP to adenosine and phosphate. Several surface-located enzymes may be involved in this hydrolysis chain, e.g., ecto-alkaline phosphatase, ecto-alkaline phosphodiesterase, ecto-apyrase or NTPDase1 (referred to as E-ATPDase), ecto-ATPase, and ecto-5'-nucleotidase (Zimmermann et al. 1986 ; Zimmermann 1994 , Zimmermann 1996 ; Zimmermann and Braun 1996 ). The membrane-associated E-ATPDase is identical to CD39, a previously characterized lymphoid cell activation antigen (Maliszewski et al. 1994 ; Kaczmarek et al. 1996 ; Wang and Guidotti 1996 ), and its suggested new name is NTPDase1 (Zimmermann et al. 1999 ). Changes in the activity and distribution of this protein have been reported in several pathological conditions. E-ATPDase/NTPDase1 is overexpressed in human melanoma cell lines, in rat ovarian tumor cells, and in multidrug-resistant breast carcinoma cells (MCF-7-AdR) (Slivinskii et al. 1993 ; Dzhandzhugazyan et al. 1998 ; Kittel et al. 2000 ). Elevated levels of extracellular ATP have also been observed in many tumors.

Few data are available regarding extracellular ATP and NTPDase activity in the pancreas. In pig pancreas, two isoforms of NTPDase1 have been characterized, purified, and identified (Laliberte et al. 1982 ; Sevigny et al. 1995 ). One of their putative roles is to modulate the extracellular concentrations of purines.

According to the authors, the E-ATPDase is strategically positioned to modulate purine-mediated actions such as fluid and electrolyte secretion, smooth muscle contraction, and blood flow (Sevigny et al. 1998 ). There are data (in the guinea pig) suggesting that, in the exocrine pancreas, luminal nucleotides may act in an autocrine or paracrine fashion to enhance duct secretion and that basolateral nucleotides, perhaps released from nerve terminals, may have an inhibitory effect (Ishiguro et al. 1999 ). However, no information is available on the regulatory role of ATP or on the physiological–pathophysiological role of NTPDase1 in human pancreas. Our goal was to describe the distribution of NTPDase1 in human pancreas in order to examine the possible correlation between enzyme activity and tumor transformation.


  Materials and Methods
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

All reagents were purchased from Sigma (St Louis, MO) unless otherwise specified. Affinity-purified rabbit anti-CFTR (cystic fibrosis transmembrane conductance regulator) was prepared in the lab of A. Nairn (Rockefeller University; New York, NY). LP2K, a mouse monoclonal anti-cytokeratin 19, was obtained from Dr. E. B. Lane (University of Dundee; Dundee, Scotland).

Preparation of Cryosections
Human pancreatic tissue blocks were obtained at surgery (IMIM; University of Barcelona). A certified clinical pathologist at the location characterized each sample. Tissue blocks were frozen in isopentane cooled by liquid nitrogen. Three- to 5-µm cryosections were cut and, after drying, fixed with acetone (-20C) for 10 min. Each slide contained both normal and tumor sections. Staining procedures were carried out in a Shandon immunostainer (Shandon Scientific; Cheshire, UK).

Enzyme Histochemistry
A lead precipitation enzyme histochemical technique was used for demonstration of NTPDase (E-ATPDase) activity (Kittel 1997 ). After fixation and several rinses in 0.07 M Tris-maleate buffer, pH 7.4, the sections were incubated in a medium containing ATP or ADP (1 mM) as substrate, 2 mM Pb(NO3)2 (capturing agent for the liberated phosphate), 1 mM levamisole (inhibitor of alkaline phosphatases; Amersham, Poole, UK), 1 mM ouabain, (Na+, K+-ATPase inhibitor; Merck, Darmstadt, Germany), 50 mM {alpha},ß-methylene-ADP (5'-nucleotidase inhibitor), and KCl (5 mM) in Tris-maleate buffer (70 mM, pH 7.4) for 30 min at room temperature (RT). Incubation was followed by three rinses in Tris-maleate buffer. The precipitate was converted to PbS with 1% (NH4)2S (1-min incubation).

Immunohistochemistry
After the enzyme histochemical reaction, immunostaining was performed to identify the main cell types in the human pancreatic cryosection. {alpha}-LP2K (1:4 dilution) was used to identify epithelial cells, amylase antibody (in undiluted solution) identified the acinar cells, or a chromogranin antibody (Biomeda; Foster City, CA; 3:1 dilution) was applied to distinguish the islet B-cells.

After blocking endogenous phosphatase activity (3 mM levamisole, 0.01% NaN3 in PBS, 10 min) and washing, nonspecific binding sites were blocked with 5% dried milk and 0.04% Tween-20 in PBS for 20 min. The primary antibody was diluted in 1% BSA–PBS and the incubation time was overnight at 4C. After washing with PBS, the secondary antibody (alkaline phosphatase-conjugated IgG, diluted in 1% BSA–PBS) was applied for 60 min at RT. After washing and preincubation with Tris (0.1 M, pH 8.2), staining was visualized with Fast Red (0.1 M, pH 8.2, 5 min). Sections were counterstained in 20% Papanicolau in PBS and, after washing with tapwater, mounted in Aquatex. Images were obtained with an Olympus BP 50 digital camera (Olympus Optical (Europa); Hamburg, Germany).

Immunostaining was also performed with {alpha}-CD39 monoclonal antibody (Ancell; Bayport, MN) on the human pancreatic cryosections. Fixation was carried out as above. After rinsing with PBS, the nonspecific binding sites were blocked with 5% BSA in PBS for 30 min and the sections were incubated overnight with CD39 antibody in 1:400 dilution at 4C. The ABC method was used and Vector VIP as chromogen (Vector Laboratories; Burlingame, CA) was applied according to the manufacturer's instructions. After washing with distilled water, sections were mounted in Aquatex and imaged on a Nikon Eclipse E 600 microscope with a Spot digital camera (Nikon; Kumagaya City, Japan) using a x20 objective.


  Results
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

The enzyme histochemical reaction used in the present work demonstrates the active NTPDase1 enzyme. Whether ATP or ADP was used as a substrate, the distribution of enzyme activity indicated by the precipitate was similar. Ecto-ATPase/E-ATPDase activity was detected as a brown lead sulfide (PbS) deposit, which is generated at sites where phosphate is liberated from the extracellular ATP/ADP during hydrolysis. Immunohistochemical staining performed after enzyme histochemistry was used to identify the different cell types. Immunostaining was also done to localize the DC39/NTPDase1-positive cells. As controls for the enzyme histochemical reaction, the substrate ATP or ADP was omitted from the reaction mixture (Fig 1A). For the immunostaining, the incubation step with the first antibody was omitted (Fig 1I).



View larger version (131K):
[in this window]
[in a new window]
 
Figure 1. Enzyme histochemistry for E-ATPDase activity and CD39/NTPDase1 immunostaining in cryosections of human pancreas. Brown deposit (lead sulfide) indicates the active enzyme and two kinds of red color (Fast Red for amylase, LP2K, and chromogranin and Vector-VIP for CD39 staining) show the immunoreactive cells. (A) Control of enzyme histochemical staining. The incubation medium did not contain substrate ATP. Counterstaining: Papanicolau–hematoxylin. Neither endothelial nor surrounding smooth muscle cells of the blood vessel (v) or acini (a) are stained. Normal human pancreatic tissue section. (B) Brown staining shows the E-ATPDase activity in the endothelial and smooth muscle cells of the blood vessel (artery). Endothelial cells of the smaller vessel are also heavily stained, but acini do not show E-ATPDase activity. Normal tissue. (C) Immunostaining for CD39/NTPDase1. The blood vessel (v), endothelial cells, and smooth muscle cells have strong immunoreactivity. Acini are not stained. Normal human pancreas. (D) Human pancreatic tumor. Enzyme histochemistry for E-ATPDase activity and immunostaining with {alpha}-amylase antibody for identifying acini. Vessel endothelial cells (arrow) and the endothelial and smooth muscle cells of the cross-sectioned blood vessel (v) have strong E-ATPDase activity but acini are not stained. The proliferation of the ducts (some of them labeled with "d") is typical of adenocarcinoma. Connective tissue around the ducts shows some very weak E-ATPDase activity. (Inset) Enzyme and immunohistochemical double staining on normal pancreatic tissue. Endothelial cells (arrow) show the enzyme activity (brown) and normal acini (a) are positive for amylase staining (red). (E) E-ATPDase histochemistry and LP2K immunostaining on normal pancreatic tissue section. Smooth muscle cells around the big duct (d) are positive and duct epithelial cells are stained for LP2K. (Inset) The same double staining on cancerous tissue section. Endothelial cells (arrow) are brown because of the enzyme activity and duct epithelial cells are stained for LP2K (red), but there is no brown deposit indicating enzyme activity around the ducts. (F) Immunostaining for CD39/NTPDase1 on a human pancreatic cryosection. Both endothelial cells (arrow) and epithelial cells of the ducts (d) are stained. Surrounding acini (a) are negative. (G) Papanicolau–hematoxylin-counterstained cryosection. Nerves (n) show E-ATPDase activity (brown deposit). Endothelial cells (arrow) are also stained. (Inset) CD39/NTPDase1 immunostaining demonstrates the same localization. Immunoreactivity (red color) is in the nerves (n). (H) Enzyme histochemical staining for E-ATPDase. Blood vessels (arrow) within and around the islet contain active enzyme. Many rounded cells of the islet (i) are also stained. (Upper inset) Enzyme and immunohistochemical double staining. Brown deposit indicates the enzyme activity in the islet (i) and the red color shows the chromogranin-positive cells of the islet. The two stainings overlap each other in some cells. (Lower inset) CD39/NTPDase1 immunostaining. The islet (i) cells are highly immunoreactive (red color). (I) Control for the immunostaining. After the enzyme histochemical reaction [endothelial cells (arrow) are positive, ducts and acini are negative], immunostaining was performed without the first antibody/ies (CD39, LP2K, {alpha}-chromogranin, {alpha}-amylase). All cell types are free of staining. Bars = 60 µm.

As described in Materials and Methods, certified clinical pathologists identified the origin of the tissue blocks used. We studied only one type of pancreatic cancer, duct adenocarcinoma. The general appearance of this cancerous pancreas differs from the normal tissue in many details. We observed proliferation and disorganization of duct epithelial cells, an increased amount of connective tissue, and no staining in the acini when amylase immunostaining was applied (Fig 1D, inset).

Endothelial cells and smooth muscle cells around blood vessels showed the strongest E-ATPDase activity in cryosections of human pancreas (Fig 1B). Acini were unstained. When CD39/NTPDase1 immunostaining was applied, the result was the same for these types of cells (Fig 1C). Each presented staining was performed on normal tissue, but, as shown in Fig 1D, the E-ATPDase activity in the endothelial cells and smooth muscle cells was not altered in cancerous pancreas. The cryosection shown in Fig 1D was cut from a tissue block of tumor origin. The vessel endothelial and smooth muscle cells are covered with the brown PbS deposit because of the active ectoenzyme. Duct epithelial cells are negative for the enzyme reaction; only the connective tissue around the group of ducts shows some very weak staining. Although amylase staining was applied to identify the acini, they were unstained because of the cancerous transformation of the tissue. In normal tissues, when amylase immunostaining was applied (Fig 1D, inset) the acini were positive and showed the red color of the Fast Red. The brown color of the endothelial cells demonstrated E-ATPDase activity.

In normal pancreas, the smooth muscle cells around the larger ducts were also stained (Fig 1E) but the intensity of this staining decreased in the cancerous tissue and the number of ducts was increased because of proliferation (Fig 1E, inset). LP2K staining confirmed the identification of the duct cells (Fig 1E and inset). Although according to the result of enzyme histochemical staining the duct cells did not bear ATPDase enzyme activity, immunostaining showed strong immunoreactivity for CD39 (Fig 1F). Some E-ATPDase activity was also detected in nerves (Fig 1G). The presence of CD39/NTPDas1 was proved with immunostaining (Fig 1G, inset). We have also demonstrated for the first time the E-ATPDase activity of the ß-cells of the islets of Langerhans (Fig 1H). ß-Cells were identified with chromogranin staining (Fig 1H, upper inset). Immunostaining for CD39 confirmed that the E-ATPDase activity demonstrated by enzyme histochemistry belongs to NTPDase1 (Fig 1H, lower inset).


  Discussion
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

NTPDase1, one of the most intensively studied members of the ecto-NTPDase enzyme family, is considered to play an important role in purinergic signaling, in thromboregulation, and in cell-protective processes by converting ATP released by damaged cells to AMP. The source of extracellular ATP can also be nerve terminals and other types of cells. ATP can be released in response to endogenous ligands and is involved in a special mode of signal transmission, so-called cascade transmission (Nitahara et al. 1995 ; Sperlagh et al. 1995 ; Vizi et al. 1997 ).

Among the nucleotide receptors, P2 receptors are selective for ATP and ADP. In 1981, when the stimulatory effect of ATP on insulin secretion in isolated perfused rat pancreas was demonstrated, it was concluded that a purinoceptor of the P2-type is likely to be present on the ß-cells of the rat pancreas (Chapal and Loubatieres-Mariani 1981 ). There are now data indicating the presence and functional role of both P2X and P2Y receptors on islet cells (Chapal et al. 1984 ; Bertrand et al. 1987 , Bertrand et al. 1989 , Bertrand et al. 1990 ; Hillaire-Buys et al. 1992 , Hillaire-Buys et al. 1994 , Hillaire-Buys et al. 1999 ; Stam et al. 1996 ). {alpha}-Cells possess adenosine receptors involved in the stimulation of glucagon secretion and ß-cells have P2 purinoceptors (for ATP and/or ADP) which increase insulin secretion (Loubatieres-Mariani and Chapal 1988 ; Hillaire-Buys et al. 1994 ; Tang et al. 1996 ). The P2Y1 gene is expressed in placenta, skeletal muscle, platelets, and pancreas, and another G-protein-coupled P2 receptor is encoded by an intronless single-copy gene that is expressed exclusively in pancreas (Ayyanathan et al. 1996 ). However, there are no data concerning the presence or absence of NTPDase1 on islet cells, although its distribution might be expected to correlate with the P2 receptors. On the other hand, the presence of 5'-nucleotidase was shown in rat pancreas about 20 years ago (Chapal et al. 1984 ) and the substrate of 5'-nucleotidase is AMP, the degradation product of NTPDase activity. Our histochemical staining is the first to demonstrate a strong NTPDase/E-ATPDase activity on the islet cells of human pancreas (Fig 1H). The presence of the entire hydrolysis chain for ATP in the human pancreas may therefore correlate with the presence of both adenosine and P2 receptors.

The presence of E-ATPDase activity has previously been demonstrated on several cell types in the exocrine pancreas of rat and pig (LeBel et al. 1980 ; Sevigny et al. 1998 ; Beaudoin et al. 1999 ). Both basolateral and apical membranes of the acinar cells were positive, as were the membranes of zymogen granules in the acinar cells. In those studies a strong signal was also observed on the duct epithelium. In contrast, we could not demonstrate any active enzyme in either acini or duct cells in normal human pancreas. Endothelial and smooth muscle cells served as intrinsic positive controls for NTPDase1 and showed the expected strong activity. It is important, however, to emphasize the difference between the immuno- and the enzyme histochemical method. The immunostaining used by Sevigny and co-workers is useful for identifying the localization pattern of the target protein molecule but usually does not reveal anything about its activity (Sevigny et al. 1998 ). In contrast, our enzyme histochemical technique demonstrates the active enzyme only. When immunostaining for CD39 was applied, the localization pattern of this protein in endothelial, smooth muscle, neural, and ß-cells was almost identical to the results of enzyme histochemical staining. In agreement with the enzyme histochemical staining, the acinar cells and especially the zymogen granules were devoid of reaction product. However, the duct epithelial cells, which did not show enzyme activity, did show CD39 immunoreactivity. This result may indicate that duct epithelial cells contain an inactive form of the enzyme.

In the tumor samples examined in this study, the transformation was of duct adenocarcinoma origin. Given the overexpression of NTPDase1 observed previously in human melanoma cell lines (Dzhandzhugazyan et al. 1998 ), ovarian tumor of rats (Slivinskii et al. 1993 ), and multidrug-resistant breast carcinoma cells (MCF-7-AdR) (Kittel et al. 2000 ), duct cells might be expected to show some NTPDase activity. Our observation that neither ductal nor acinar cells had E-ATPDase activity in the human pancreas may indicate a significant difference in the distribution and functions of NTPDases in different species.

Other cells in the human pancreas, such as endothelial cells, smooth muscle cells, nerves and, to a lesser extent, fibroblasts, showed both E-ATPDase activity and CD39 immunoreactivity. This finding is in agreement with previous experience in other types of tissue. Endothelial cells and smooth muscle cells were among the first cell types in which E-ATPase/E-ATPDase activity was demonstrated (Cote et al. 1992 ; Cunningham et al. 1993 ). In addition, the role of E-ATPases in the nervous system has been extensively studied (Zimmermann 1996 ). Our present work reveals that, in the newly formed regions of cancerous tissue, E-ATPDase activity is diminished in the smooth muscle cells around the ducts and is absent from the connective tissue. Only few and controversial data are available about the relation between NTPDases and tumor formation (e.g., Gutensohn and Jahn 1988 ; Agteresch et al. 1999 ). The cascade of ectonucleotidases, including NTPDase1, may have a protective function by keeping extracellular ATP and adenosine levels within physiological limits. Therefore, we hypothesize that the significantly diminished activity of NTPDase1 in the tissues surrounding the ducts may be associated with tumor formation in human pancreas. This hypothesis can be supported by another observation. NTPDase1 is generally said to be evenly distributed in the membranes of the cells. However, we have observed that in cell types which possess caveolae, specialized membrane invaginations involved in signaling, NTPDase1 is preferentially targeted to these membrane microdomains (Kittel and Bacsy 1994 ; Kittel 1997 , Kittel 1999 ). Several molecules involved in signaling (receptors, eNOS, G-proteins), which are targeted to the caveolae, undergo post-translational modifications (palmitoylation). It is the same for NTPDase1 (Kittel et al. 1999 ; Koziak et al. 2000 ), suggesting a possible role of NTPDase1 in signal transmission. Smooth muscle cells, for example, possess many caveolae. The diminished E-ATPDase activity in the smooth muscle cells around the ducts in cancerous pancreas may therefore be significant. It may affect the communication between neighboring cells and contribute to the process of malignant transformation. Conversely, it is also possible that the loss of enzyme activity is a consequence of tumor transformation.

In conclusion, our findings suggest that NTPDase1 is not expressed in acinar cells of the human pancreas and that the duct cells express only an inactive form of the enzyme. This may indicate a different role of NTPDase1 in human pancreas compared with other species, and its differential distribution in the surrounding tissues may be associated with the processes that lead to tumor transformation.


  Acknowledgments

Supported by INCO program of the European Comission (ERB IC20-CT98-0202), Hungarian Committee for Technical Development (EU-98-D9-065), and Hungarian Medical Research Council 282/2000 grants, as well as Biomed contract BMH4-CT98-3805 and by grant PM97-0077 from the Direccion General de Enseñanza Superior e Investigación Científica (Spain) Grant.

We thank Drs F.X. Real and Anouchka Skoudy (IMIM; Barcelona, Spain) for their valuable help during the experimental work. We also thank Drs S.C. Robson, (Harvard BIDMC; Boston), J. Sevigny (Harvard BIDMC; Boston), and M.C. Steward (Manchester Univ., UK) for critical reading of the manuscript.

Received for publication April 23, 2001; accepted November 14, 2001.


  Literature Cited
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Agteresch HJ, Dagnelie PC, van den Berg JW, Wilson JH (1999) Adenosine triphosphate: established and potential clinical applications. Drugs 58:211-232[Medline]

Ayyanathan K, Webbs TE, Sandhu AK, Athwal RS, Barnard EA, Kunapuli SP (1996) Cloning and chromosomal localization of the human P2Y1 purinoceptor. Biochem Biophys Res Commun 218:783-788[Medline]

Beaudoin AR, Grondin G, Enjyoji K, Robson SC, Sevigny J, Fische B, Grendon F-P (1999) The physiological role of NTPDases (ATP diphosphohydrolases) in mammals. In Vanduffel L, Lemmens R, eds. Ecto-ATPases and Related Ectonucleotidases. Maastricht, The Netherlands, Shaker Publishing, 125-135

Bertrand G, Chapal J, Loubatieres–Mariani MM, Roye M (1987) Evidence for two different P2-purinoceptors on beta cell and pancreatic vascular bed. Br J Pharmacol 91:783-787[Abstract]

Bertrand G, Gross R, Chapal J, Loubatieres–Mariani MM (1989) Difference in the potentiating effect of adenosine triphosphate and alpha, beta-methylene ATP on the biphasic insulin response to glucose. Br J Pharmacol 98:998-1004[Abstract]

Bertrand G, Gross R, Ribes G, Loubatieres–Mariani MM (1990) P2 purinoceptor agonists stimulate somatostatin secretion from dog pancreas. Eur J Pharmacol 182:369-373[Medline]

Chapal J, Loubatieres–Mariani MM (1981) Attempt to antagonize the stimulatory effect or ATP on insulin secretion. Eur J Pharmacol 74:127-134[Medline]

Chapal J, Loubatieres–Mariani MM, Roye M, Zerbib A (1984) Effects of adenosine, adenosine triphosphate and structural analogues on glucagon secretion from the perfused pancreas of rat in vitro. Br J Pharmacol 83:927-933[Abstract]

Côté YP, Filep JG, Battistini B, Gauvreau J, Sirois P, Beaudoin AR (1992) Characterization of ATP-diphosphohydrolase activities in the intima and media of the bovine aorta: evidence for a regulatory role in platelet activation in vitro. Biochim Biophys Acta 1139:133-142[Medline]

Cunningham HB, Yazaki PJ, Domingo RC, Oades KV, Bohlen H, Sabbadini RA, Dahms AS (1993) The skeletal muscle transverse tubular Mg-ATPase: identity with Mg-ATPases of smooth muscle and brain. Arch Biochem Biophys 303:32-43[Medline]

Dzhandzhugazyan KN, Kirkin AF, Thor Straten P, Zeuthen J (1998) Ecto-ATP diphosphohydrolase/CD39 is overexpressed in differentiated human melanomas. FEBS Lett 430:227-230[Medline]

Gutensohn W, Jahn H (1988) Qualitative and quantitative differences between Burkitt lymphoma and lymphoblastoid cell lines in the expression of membrane ecto-nucleotidases and in the response to agonists of the A2-type adenosine receptor. Int J Cancer 41:436-441[Medline]

Hillaire–Buys D, Chapal J, Bertrand G, Petit P, Loubatieres–Mariani MM (1994) Purinergic receptors on insulin-secreting cells. Fund Clin Pharmacol 8:117-127[Medline]

Hillaire–Buys D, Dietz S, Chapal J, Petit P, Loubatieres–Mariani MM (1999) Involvement of P2X and P2U receptors in the constrictor effect of ATP on the pancreatic vascular bed. J Soc Biol 193:57-61[Medline]

Hillaire–Buys D, Gross R, Chapal J, Ribes G, Loubatieres–Mariani MM (1992) P2y purinoceptor responses of beta cells and vascular bed are preserved in diabetic rat pancreas. Br J Pharmacol 106:610-615[Abstract]

Ishiguro H, Naruse S, Kitagawa M, Hayakawa T, Case RM, Steward MC (1999) Luminal ATP stimulates fluid and HCO3- secretion in guinea-pig pancreatic duct. J Physiol (Lond) 519:551-558[Abstract/Free Full Text]

Kaczmarek E, Koziak K, Sévigny J, Siegel JB, Anrather J, Beaudoin AR, Bach FH, Robson SC (1996) Identification and characterization of CD39 vascular ATP diphosphohydrolase. J Biol Chem 271:33116-33122[Abstract/Free Full Text]

Kittel A (1997) Role of ecto-ATPases, based on histochemical investigations. Evidences and doubts. In Plesner TK, Knowles AF, eds. Ecto-ATPases: Recent Progress on Structure and Function. New York, Plenum Publishing, 65-72

Kittel A (1999) Lipopolysaccharide treatment modifies pH- and cation-dependent ecto-ATPase activity of endothelial cells. J Histochem Cytochem 47:393-400[Abstract/Free Full Text]

Kittel A, Bácsy E (1994) Ecto-ATPases and 5'-nucleotidases in the caveolae of smooth muscle. Enzyme-histochemical evidence may indicate a role for caveolae in neurotransmission. Cell Biol Int 18:875-879[Medline]

Kittel A, Kaczmarek E, Sevigny J, Lengyel K, Csizmadia E, Robson SC (1999) CD39 as a caveolar-associated ectonucleotidase. Biochem Biophys Res Commun 262:596-599[Medline]

Kittel A, Varga G, Liscovitch M (2000) Ecto-ATPases and caveolae in multidrug-resistant cancer cells. Eur J Neurosci 12:225

Koziak K, Kaczmarek E, Kittel A, Sevigny J, Blusztajn JK, Schulte Am Esch J, II, Imai M, Guckelberger O, Goepfert C, Qawi I, Robson SC (2000) Palmitoylation targets CD39/endothelial ATP diphosphohydrolase to caveolae. J Biol Chem 275:2057-2062. [in process citation][Abstract/Free Full Text]

Laliberte JF, St-Jean P, Beaudoin AR (1982) Kinetic effects of Ca2+ and Mg2+ on ATP hydrolysis by the purified ATP diphosphohydrolase. J Biol Chem 257:3869-3874[Abstract/Free Full Text]

LeBel D, Poirier GG, Phaneuf S, St-Jean P, Laliberte JF, Beaudoin AR (1980) Characterization and purification of a calcium-sensitive ATP diphosphohydrolase from pig pancreas. J Biol Chem 255:1227-1233[Abstract/Free Full Text]

Loubatieres–Mariani MM, Chapal J (1988) Purinergic receptors involved in the stimulation of insulin and glucagon secretion. Diabetes Metab 14:119-126

Maliszewski CR, DeLepesse GJT, Schoenborn MA, Armitage RJ, Fanslow WC, Nakajima T, Baker E, Sutherland GR, Poindexter K, Birks C, Alpert A, Friend D, Gimpel SD, Gayle RB (1994) The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization. J Immunol 153:3574-3583[Abstract/Free Full Text]

Nitahara K, Kittel A, Liang SD, Vizi ES (1995) A1-receptor-mediated effect of adenosine on the release of acetylcholine from the myenteric plexus: role and localization of ecto-ATPase and 5'-nucleotidase. Neuroscience 67:159-168[Medline]

Sévigny J, Côté YP, Beaudoin AR (1995) Purification of pancreas type-I ATP diphosphohydrolase and identification by affinity labelling with the 5'-p- fluorosulphonylbenzoyladenosine ATP analogue. Biochem J 312:351-356[Medline]

Sévigny J, Grondin G, Gendron F-P, Roy J, Beaudoin AR (1998) Demonstration and immunolocalization of ATP diphosphohydrolase in the pig digestive system. Am J Physiol 275:G473-482[Abstract/Free Full Text]

Slivinskii GG, Bushneva IA, Magda IN (1993) A comparative study of the ectophosphatase activity in different subpopulations of tumor cells. Tsitologiia 35:94-100[Medline]

Sperlágh B, Kittel A, Lajtha A, Vizi ES (1995) ATP acts as fast neurotransmitter in rat habenula: neurochemical and enzymecytochemical evidence. Neuroscience 66:915-920[Medline]

Stam NJ, Klomp J, Van de Heuvel N, Olijve W (1996) Molecular cloning and characterization of a novel orphan receptor (P2P) expressed in human pancreas that shows high structural homology to the P2U purinoceptor. FEBS Lett 384:260-264[Medline]

Tang J, Pugh W, Polonsky KS, Zhang H (1996) Preservation of insulin secretory responses to P2 purinoceptor agonists in Zucker diabetic fatty rats. Am J Physiol 270:E504-512[Abstract/Free Full Text]

Vizi ES, Liang SD, Sperlágh B, Kittel A, Jurányi Z (1997) Studies on the release and extracellular metabolism of endogenous ATP in rat superior cervical ganglion: support for neurotransmitter role of ATP. Neuroscience 79:893-903[Medline]

Wang TF, Guidotti G (1996) CD39 is an ecto-(Ca2+,Mg2+)-apyrase. J Biol Chem 271:9898-9901[Abstract/Free Full Text]

Zimmermann H (1994) Signalling via ATP in the nervous system. Trends Neurosci 17:420-426[Medline]

Zimmermann H (1996) Extracellular purine metabolism. Drug Dev Res 39:337-352

Zimmermann H, Beaudoin AR, Bollen M, Goding JW, Guidotti G, Kirley TL, Robson SC, Sano K (1999) Proposed nomenclature for two novel nucleotide hydrolysing enzyme families expressed on the cell surface. In Vanduffel L, Lemmens R, eds. Ecto-ATPases and Related Ecto-nucleotidase. Maastricht, The Netherlands, Shaker Publishing, 1-8

Zimmermann H, Braun N (1996) Extracellular metabolism of nucleotides in the nervous system. J Autonom Pharmacol 16:397-400[Medline]

Zimmermann H, Grondal EJM, Keller F (1986) Hydrolysis of ATP and formation of adenosine at the surface of cholinergic nerve endings. In Kreutzberg GW, Reddington M, Zimmermann H, eds. Cellular Biology of Ecto-Enzymes. Berlin, Heidelberg, Springer-Verlag, 35-48